CN106616622A - 一种黑蒜山楂脆片及其制作方法 - Google Patents
一种黑蒜山楂脆片及其制作方法 Download PDFInfo
- Publication number
- CN106616622A CN106616622A CN201611239169.8A CN201611239169A CN106616622A CN 106616622 A CN106616622 A CN 106616622A CN 201611239169 A CN201611239169 A CN 201611239169A CN 106616622 A CN106616622 A CN 106616622A
- Authority
- CN
- China
- Prior art keywords
- hawthorn
- black garlic
- garlic
- black
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 241001092040 Crataegus Species 0.000 claims abstract description 56
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims abstract description 56
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims abstract description 56
- 235000009685 Crataegus X maligna Nutrition 0.000 claims abstract description 56
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims abstract description 56
- 235000009486 Crataegus bullatus Nutrition 0.000 claims abstract description 56
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims abstract description 56
- 235000009682 Crataegus limnophila Nutrition 0.000 claims abstract description 56
- 235000004423 Crataegus monogyna Nutrition 0.000 claims abstract description 56
- 235000002313 Crataegus paludosa Nutrition 0.000 claims abstract description 56
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims abstract description 56
- 241000383638 Allium nigrum Species 0.000 claims abstract description 55
- 239000000843 powder Substances 0.000 claims abstract description 39
- 240000002234 Allium sativum Species 0.000 claims abstract description 38
- 235000004611 garlic Nutrition 0.000 claims abstract description 38
- 238000001035 drying Methods 0.000 claims abstract description 19
- 239000002994 raw material Substances 0.000 claims abstract description 9
- 238000007493 shaping process Methods 0.000 claims abstract description 3
- 238000004806 packaging method and process Methods 0.000 claims description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 235000011837 pasties Nutrition 0.000 claims description 8
- 239000000654 additive Substances 0.000 claims description 3
- 230000000996 additive effect Effects 0.000 claims description 3
- 239000012467 final product Substances 0.000 claims description 3
- 235000011194 food seasoning agent Nutrition 0.000 claims description 3
- 235000013305 food Nutrition 0.000 abstract description 28
- 230000000694 effects Effects 0.000 abstract description 21
- 238000005516 engineering process Methods 0.000 abstract description 6
- 238000013329 compounding Methods 0.000 abstract description 3
- 230000002708 enhancing effect Effects 0.000 abstract description 3
- 238000003912 environmental pollution Methods 0.000 abstract description 2
- 238000004519 manufacturing process Methods 0.000 abstract description 2
- 238000009776 industrial production Methods 0.000 abstract 1
- 238000002156 mixing Methods 0.000 abstract 1
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 16
- 239000000463 material Substances 0.000 description 12
- 239000000047 product Substances 0.000 description 12
- 150000003839 salts Chemical class 0.000 description 10
- 235000002639 sodium chloride Nutrition 0.000 description 10
- 239000008157 edible vegetable oil Substances 0.000 description 9
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 9
- 235000013923 monosodium glutamate Nutrition 0.000 description 9
- 239000004223 monosodium glutamate Substances 0.000 description 9
- 229910052757 nitrogen Inorganic materials 0.000 description 8
- 238000000227 grinding Methods 0.000 description 7
- 150000002632 lipids Chemical class 0.000 description 7
- 238000009461 vacuum packaging Methods 0.000 description 7
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 239000000661 sodium alginate Substances 0.000 description 6
- 235000010413 sodium alginate Nutrition 0.000 description 6
- 229940005550 sodium alginate Drugs 0.000 description 6
- 229920001817 Agar Polymers 0.000 description 5
- 239000008272 agar Substances 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 235000001014 amino acid Nutrition 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 239000000686 essence Substances 0.000 description 4
- 239000011229 interlayer Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000001603 reducing effect Effects 0.000 description 4
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 description 3
- 235000002566 Capsicum Nutrition 0.000 description 3
- 240000008574 Capsicum frutescens Species 0.000 description 3
- 241000657480 Crataegus pinnatifida Species 0.000 description 3
- 235000007129 Cuminum cyminum Nutrition 0.000 description 3
- 244000304337 Cuminum cyminum Species 0.000 description 3
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 3
- 208000034189 Sclerosis Diseases 0.000 description 3
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 3
- 244000089698 Zanthoxylum simulans Species 0.000 description 3
- 235000010489 acacia gum Nutrition 0.000 description 3
- 239000001785 acacia senegal l. willd gum Substances 0.000 description 3
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical group C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 description 3
- 235000010081 allicin Nutrition 0.000 description 3
- 230000003712 anti-aging effect Effects 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 210000001367 artery Anatomy 0.000 description 3
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 239000001390 capsicum minimum Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 230000029087 digestion Effects 0.000 description 3
- 238000000855 fermentation Methods 0.000 description 3
- 230000004151 fermentation Effects 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 235000012907 honey Nutrition 0.000 description 3
- 230000002218 hypoglycaemic effect Effects 0.000 description 3
- 230000001077 hypotensive effect Effects 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 3
- -1 methacrylic trithio Compound Chemical class 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- 239000000811 xylitol Substances 0.000 description 3
- 235000010447 xylitol Nutrition 0.000 description 3
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 3
- 229960002675 xylitol Drugs 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 2
- YWHLKYXPLRWGSE-UHFFFAOYSA-N Dimethyl trisulfide Chemical compound CSSSC YWHLKYXPLRWGSE-UHFFFAOYSA-N 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 208000001953 Hypotension Diseases 0.000 description 2
- 235000012629 Mentha aquatica Nutrition 0.000 description 2
- 240000000275 Persicaria hydropiper Species 0.000 description 2
- 235000017337 Persicaria hydropiper Nutrition 0.000 description 2
- 235000004442 Polygonum persicaria Nutrition 0.000 description 2
- ZFAHNWWNDFHPOH-YFKPBYRVSA-N S-allylcysteine Chemical compound OC(=O)[C@@H](N)CSCC=C ZFAHNWWNDFHPOH-YFKPBYRVSA-N 0.000 description 2
- JMFSHKGXVSAJFY-UHFFFAOYSA-N Saponaretin Natural products OCC(O)C1OC(Oc2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C1O JMFSHKGXVSAJFY-UHFFFAOYSA-N 0.000 description 2
- 241000534944 Thia Species 0.000 description 2
- MOZJVOCOKZLBQB-UHFFFAOYSA-N Vitexin Natural products OCC1OC(Oc2c(O)c(O)cc3C(=O)C=C(Oc23)c4ccc(O)cc4)C(O)C(O)C1O MOZJVOCOKZLBQB-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 230000003288 anthiarrhythmic effect Effects 0.000 description 2
- 230000003266 anti-allergic effect Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- MGNZXYYWBUKAII-UHFFFAOYSA-N cyclohexa-1,3-diene Chemical compound C1CC=CC=C1 MGNZXYYWBUKAII-UHFFFAOYSA-N 0.000 description 2
- LPIQUOYDBNQMRZ-UHFFFAOYSA-N cyclopentenylidene Natural products C1CC=CC1 LPIQUOYDBNQMRZ-UHFFFAOYSA-N 0.000 description 2
- 238000004332 deodorization Methods 0.000 description 2
- PFRGXCVKLLPLIP-UHFFFAOYSA-N diallyl disulfide Chemical compound C=CCSSCC=C PFRGXCVKLLPLIP-UHFFFAOYSA-N 0.000 description 2
- UBAXRAHSPKWNCX-UHFFFAOYSA-N diallyl trisulfide Chemical compound C=CCSSSCC=C UBAXRAHSPKWNCX-UHFFFAOYSA-N 0.000 description 2
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 208000021822 hypotensive Diseases 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 125000005395 methacrylic acid group Chemical group 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- RGSFGYAAUTVSQA-UHFFFAOYSA-N pentamethylene Natural products C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 150000008442 polyphenolic compounds Chemical class 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- PFTAWBLQPZVEMU-ZFWWWQNUSA-N (+)-epicatechin Natural products C1([C@@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-ZFWWWQNUSA-N 0.000 description 1
- PFTAWBLQPZVEMU-UKRRQHHQSA-N (-)-epicatechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-UKRRQHHQSA-N 0.000 description 1
- SBZWTSHAFILOTE-SOUVJXGZSA-N (2R,3S,4S)-leucocyanidin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3[C@H](O)[C@@H]2O)=CC=C(O)C(O)=C1 SBZWTSHAFILOTE-SOUVJXGZSA-N 0.000 description 1
- LUEWUZLMQUOBSB-FSKGGBMCSA-N (2s,3s,4s,5s,6r)-2-[(2r,3s,4r,5r,6s)-6-[(2r,3s,4r,5s,6s)-4,5-dihydroxy-2-(hydroxymethyl)-6-[(2r,4r,5s,6r)-4,5,6-trihydroxy-2-(hydroxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-4,5-dihydroxy-2-(hydroxymethyl)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol Chemical compound O[C@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@@H](O[C@@H]2[C@H](O[C@@H](OC3[C@H](O[C@@H](O)[C@@H](O)[C@H]3O)CO)[C@@H](O)[C@H]2O)CO)[C@H](O)[C@H]1O LUEWUZLMQUOBSB-FSKGGBMCSA-N 0.000 description 1
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 1
- FRWNAQDBODEVAL-VMPITWQZSA-N (5e)-5-[(4-nitrophenyl)methylidene]-2-sulfanylidene-1,3-thiazolidin-4-one Chemical compound C1=CC([N+](=O)[O-])=CC=C1\C=C\1C(=O)NC(=S)S/1 FRWNAQDBODEVAL-VMPITWQZSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- QNMKGMUGYVWVFQ-UHFFFAOYSA-N 2alpha-Hydroxyursolic acid Natural products CC12CC(O)C(O)C(C)(C)C1CCC1(C)C2CC=C2C3C(C)C(C)(C)CCC3(C(O)=O)CCC21C QNMKGMUGYVWVFQ-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- PNWSHHILERSSLF-UHFFFAOYSA-N 4-methylbenzene-1,3-dicarboxylic acid Chemical class CC1=CC=C(C(O)=O)C=C1C(O)=O PNWSHHILERSSLF-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 241000234282 Allium Species 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 241001465677 Ancylostomatoidea Species 0.000 description 1
- 241001313855 Bletilla Species 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 241000675108 Citrus tangerina Species 0.000 description 1
- 235000008440 Crataegus cuneata Nutrition 0.000 description 1
- 235000014283 Crataegus pinnatifida var major Nutrition 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 240000006927 Foeniculum vulgare Species 0.000 description 1
- 235000004204 Foeniculum vulgare Nutrition 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 229920002581 Glucomannan Polymers 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 235000000177 Indigofera tinctoria Nutrition 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 206010027439 Metal poisoning Diseases 0.000 description 1
- 206010054949 Metaplasia Diseases 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 241001480055 Quercus mongolica Species 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- ZFAHNWWNDFHPOH-UHFFFAOYSA-N S-Allyl-L-cystein Natural products OC(=O)C(N)CSCC=C ZFAHNWWNDFHPOH-UHFFFAOYSA-N 0.000 description 1
- ZONYXWQDUYMKFB-UHFFFAOYSA-N SJ000286395 Natural products O1C2=CC=CC=C2C(=O)CC1C1=CC=CC=C1 ZONYXWQDUYMKFB-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241001502500 Trichomonadida Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N acrylic acid group Chemical group C(C=C)(=O)O NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000003257 anti-anginal effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000002929 anti-fatigue Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000001857 anti-mycotic effect Effects 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000000884 anti-protozoa Effects 0.000 description 1
- 239000002543 antimycotic Substances 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000000496 cardiotonic agent Substances 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000007969 cellular immunity Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- 230000001713 cholinergic effect Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- MDZKJHQSJHYOHJ-UHFFFAOYSA-N crataegolic acid Natural products C1C(O)C(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MDZKJHQSJHYOHJ-UHFFFAOYSA-N 0.000 description 1
- 235000019503 curry powder Nutrition 0.000 description 1
- 150000001935 cyclohexenes Chemical class 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- WQOXQRCZOLPYPM-UHFFFAOYSA-N dimethyl disulfide Chemical compound CSSC WQOXQRCZOLPYPM-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 206010014881 enterobiasis Diseases 0.000 description 1
- LPTRNLNOHUVQMS-UHFFFAOYSA-N epicatechin Natural products Cc1cc(O)cc2OC(C(O)Cc12)c1ccc(O)c(O)c1 LPTRNLNOHUVQMS-UHFFFAOYSA-N 0.000 description 1
- 235000012734 epicatechin Nutrition 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- 229930003949 flavanone Natural products 0.000 description 1
- 150000002207 flavanone derivatives Chemical class 0.000 description 1
- 235000011981 flavanones Nutrition 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 150000002213 flavones Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229940074391 gallic acid Drugs 0.000 description 1
- 235000004515 gallic acid Nutrition 0.000 description 1
- 235000021398 garlic paste Nutrition 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 229940046240 glucomannan Drugs 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 230000004727 humoral immunity Effects 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-M hydrosulfide Chemical compound [SH-] RWSOTUBLDIXVET-UHFFFAOYSA-M 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000002434 immunopotentiative effect Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229940097275 indigo Drugs 0.000 description 1
- COHYTHOBJLSHDF-UHFFFAOYSA-N indigo powder Natural products N1C2=CC=CC=C2C(=O)C1=C1C(=O)C2=CC=CC=C2N1 COHYTHOBJLSHDF-UHFFFAOYSA-N 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- MYXNWGACZJSMBT-VJXVFPJBSA-N isovitexin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(OC(=CC2=O)C=3C=CC(O)=CC=3)C2=C1O MYXNWGACZJSMBT-VJXVFPJBSA-N 0.000 description 1
- OYJCWTROZCNWAA-UHFFFAOYSA-N isovitexin Natural products OCC1OC(C(O)C(O)C1O)c2c(O)cc3CC(=CC(=O)c3c2O)c4ccc(O)cc4 OYJCWTROZCNWAA-UHFFFAOYSA-N 0.000 description 1
- 208000008127 lead poisoning Diseases 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 229950002835 leucocianidol Drugs 0.000 description 1
- SBZWTSHAFILOTE-UHFFFAOYSA-N leucocianidol Natural products OC1C(O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 SBZWTSHAFILOTE-UHFFFAOYSA-N 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- MDZKJHQSJHYOHJ-LLICELPBSA-N maslinic acid Chemical compound C1[C@@H](O)[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MDZKJHQSJHYOHJ-LLICELPBSA-N 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000015689 metaplastic ossification Effects 0.000 description 1
- 125000005394 methallyl group Chemical group 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000002107 myocardial effect Effects 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 150000004780 naphthols Chemical class 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- GQPLMRYTRLFLPF-UHFFFAOYSA-N nitrous oxide Inorganic materials [O-][N+]#N GQPLMRYTRLFLPF-UHFFFAOYSA-N 0.000 description 1
- 235000021049 nutrient content Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 238000011017 operating method Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000002893 slag Substances 0.000 description 1
- 239000003998 snake venom Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 150000003464 sulfur compounds Chemical class 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 229960001367 tartaric acid Drugs 0.000 description 1
- DKVBOUDTNWVDEP-NJCHZNEYSA-N teicoplanin aglycone Chemical compound N([C@H](C(N[C@@H](C1=CC(O)=CC(O)=C1C=1C(O)=CC=C2C=1)C(O)=O)=O)[C@H](O)C1=CC=C(C(=C1)Cl)OC=1C=C3C=C(C=1O)OC1=CC=C(C=C1Cl)C[C@H](C(=O)N1)NC([C@H](N)C=4C=C(O5)C(O)=CC=4)=O)C(=O)[C@@H]2NC(=O)[C@@H]3NC(=O)[C@@H]1C1=CC5=CC(O)=C1 DKVBOUDTNWVDEP-NJCHZNEYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 150000003568 thioethers Chemical class 0.000 description 1
- 229940098465 tincture Drugs 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 229940096998 ursolic acid Drugs 0.000 description 1
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- SGEWCQFRYRRZDC-VPRICQMDSA-N vitexin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O SGEWCQFRYRRZDC-VPRICQMDSA-N 0.000 description 1
- PZKISQRTNNHUGF-UHFFFAOYSA-N vitexine Natural products OC1C(O)C(O)C(CO)OC1OC1=C(O)C=C(O)C2=C1OC(C=1C=CC(O)=CC=1)=CC2=O PZKISQRTNNHUGF-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明涉及一种具有保健功效的黑蒜山楂脆片食品及该脆片的制作方法。黑蒜山楂脆片是以山楂粉、黑蒜为原料，经混合、成型、烘干制作而成；其中山楂粉、黑大蒜按以下重量百分比进行配比：山楂粉85%～99%，黑大蒜1%～15%。本发明工艺简单，易于掌控，生产成本低，无环境污染，能够实现工业化生产，将具有保健功效的黑大蒜和具有增强大蒜功效作用同时也具有很好保健作用的山楂复配制作具有保健功效的脆片食品，一定会受到消费者的青睐。
Description
技术领域
本发明属于食品加工技术领域，涉及一种具有保健功能的黑蒜山楂脆片食品，同时还涉及该黑蒜山楂脆片食品的制作方法。
背景技术
大蒜，也称蒜，蒜头，为百合科葱属植物蒜Allium satium L.的鳞茎。其化学成分：鳞茎含挥发油，油中主要成分为大蒜辣素，为一种植物杀菌素。此外尚含有微量的碘等。新鲜大蒜中无大蒜辣素，而有一种大蒜氨酸，此酸经大蒜中的大蒜酶分解产生大蒜辣素及两个二硫化丙烯基。大蒜挥发油所含硫化物为甲基烯丙基一硫化物、二甲基二硫化物、二烯丙基一硫化物、甲基烯丙基二硫化物、二甲基三硫化物、二烯丙基二硫化物、甲基烯丙基三硫化物和二烯丙基三硫化物。近年来有人对云南曲靖产大蒜挥发油进行了分析，鉴定了20个化合物：6-甲基-1-1硫杂-2,4-环己二烯；5-甲基-1，2-二硫杂-3-环戊烯；4-甲基-1,2-二硫杂-3-环戊烯；4-乙烯基-1,2,3-三硫杂-5-环已烯及甲基烯丙基五硫醚等。此外，还含有糖类、氨基酸类、脂质类、维生素、无机盐、微量元素等。现代药理研究证明其药理及功效有消肿，解毒，杀虫。用于痈疖癣疮，痨咳痢泻，钩虫蛲虫病等。药理研究：①防治肿瘤，阻断亚硝胺合成，抑制癌细胞，对食管癌前病变有明显抑制作用；②提高细胞免疫、体液免疫和非特异性免疫功能，是一种良好的免疫促进剂；③抗细菌，抗真菌，抑制病毒，抗原虫和滴虫；④抑制血小板聚集，改善微循环，降血压，降血脂及溶血栓作用，可明显减轻动脉粥样硬化进展及降低心肌梗死发生率；⑤降血糖，提高胰岛素水平，促进内源性胰岛素分泌；⑥抑制***生成；⑦兴奋子宫；⑧改善慢性铅中毒症状，抗蛇毒作用；⑨钙拮抗作用及扩张血管作用；⑩清除自由基和抗氧化作用，保护脑细胞和保肝作用（贾公孚主编，临床药物新用联用大全，2006年12月第2版，737页）。由于大蒜在疾病治疗方面的应用疗效可靠，学者们研制的大蒜酊、糖浆、片剂、胶囊、注射剂等诸多制剂品种被广泛应用于医学临床。大蒜可直接食用或作为烹饪佐料应用，在我国更有历史性和普遍性，可作为健胃消食、防病治病的保健性食品，近年来得到国际市场的认可，其消费量逐年增长。近年来的研究结果表明，食用大蒜具有高效抗氧化性，促进人体新陈代谢，有抗疲劳、抗应激的效果，它还有激活免疫***，抗病毒、抗细菌、抗感染、防止动脉硬化、高血压、抗衰老的效果，特别美国设计食品计划中，大蒜被列为抗癌作用的植物性代表食品。但是，由于大蒜的特殊成分散发的强烈的刺激性气味和对消化道产生的不良刺激反应，使食用者呼气中带有强烈的、令人难闻的蒜臭气味，而被众多人士限制食用，使其对人体健康有效的大蒜食品不能得到广泛普及食用。黑大蒜是经过高温高湿的环境自然发酵而制得，经过大蒜自身的物理化学变化，不仅口味酸甜，食用不会产生难闻的口气，而多酚与游离氨基酸的含量大大超过生蒜，同时产生了艾桥恩及 S-烯丙基半胱氨酸，水溶性抗氧化物质是普通大蒜的 8.7 倍，脂溶性抗氧化物是生蒜的 79倍，有增强人体免疫力、抗过敏、抗衰老、抗癌、抑制动脉硬化、平稳血压、降血脂、降血糖、降低胆固醇、治疗便秘、美容等功效。由于黑大蒜的营养价值丰富，且食后无蒜臭味，便成为人们保健食用的时尚消费品。对具有很好保健功效的黑大蒜或山楂作为保健食品市场有片剂、胶囊、颗粒剂等剂型，缺乏食品的特色，脆片食品由于口感松脆，色香，味美，成为时尚流行的休闲食品。目前市场上为数较多的以蔬菜和水果为主要原料制成的脆片，很受消费者欢迎。将具有保健功效的黑大蒜和具有增强大蒜功效作用同时也具有很好保健作用的山楂复配制作成具有保健功能的脆片食品，一定也会受到消费者的青睐。
发明内容
本发明的目的是提供一种黑蒜山楂脆片食品。
本发明的目的还在于提供一种黑蒜山楂脆片的制作方法。
为了实现本发明，具体采用了以下技术方案：
本发明的黑蒜山楂脆片，是以山楂粉、黑大蒜为原料，经混合、成型、烘干而成。
其中山楂粉、黑大蒜按以下重量百分比进行配比：山楂粉85%～99%，黑大蒜1%～15%。
进一步优化的重量百分比配比比例为：山楂粉90%～95%，黑大蒜5%～10%。
其中所述的黑大蒜是由本发明申请人母公司（徐州绿之野生物食品有限公司）依据国家发明专利（ZL201210249529.8）开发的原材料产品，其制备方法是根据该发明专利权利要求1步骤（二）的技术方案获得的黑大蒜成品，具体步骤是（1）浸泡：选用步骤（一）方法制得的脱臭干制大蒜，加入带有密封盖的夹层不锈钢蒸煮锅内，加入纯净水，用水量至浸没干制大蒜为宜，常温浸泡 20～30 分钟；（2）蒸煮：将夹层锅盖盖紧，经夹层通入蒸汽加热煮沸，在煮沸 25～35 分钟后，即减缓蒸汽通入量，进行保温发酵；（3）保温发酵：通过夹层蒸汽流量调控，使锅内温度保持在 90～100℃，发酵36～42 小时；（4）干燥：将发酵好的黑大蒜放入设置温度为 45～55℃烘房内，进行干燥，使水分含量在 38～42%，即得黑大蒜成品。当然，在实施例的步骤操作工艺中，首先是对该发明专利说明书全文较为了解的基础上进行的，比如该专利（ZL201210249529.8）在加工生产黑大蒜的过程中，是由该发明专利权利要求1步骤（一）制备脱臭干制大蒜成品的基础上进一步按照步骤（二）的技术方案制得黑大蒜成品，制得的黑大蒜工艺稳定，产品性质稳定，具有很好的质量效果，作为本发明的原料使用是有保证的。
山楂，采用符合药材使用的山楂饮片，山楂粉可采用超微粉碎设备粉碎成300～800目的超微粉。
黑大蒜是一种发酵型的大蒜制成品，不仅有效地解决了大蒜的异味和臭味，而且营养价值高，其味香甘甜，口味醇和，食后对胃无刺激性，且具保健功效，很受消费者欢迎。黑大蒜具有多种生理活性功能，其抗氧化性和提高免疫力均高于普通大蒜。通过发酵制作的黑大蒜不仅使大蒜的不良臭味得到消除，同时使品质有了较大提升，有效成分得到保护和提高，其中多酚与游离氨基酸的含量大大超过生蒜，同时产生了艾桥恩及 S-烯丙基-L-半胱氨酸，水溶性抗氧化物质是普通大蒜的 8.7倍，脂溶性抗氧化物是生蒜的 79倍，有增强人体免疫力、抗过敏、抗衰老、抗癌、抑制动脉硬化、平稳血压、降血脂、降血糖、降低胆固醇、治疗便秘、美容等功效。
为了改善黑蒜山楂脆片食品的口感和风味，还可以加入山楂粉、黑大蒜总量1%～15%的添加剂。
其中添加剂主要有甜味剂（如L-***糖、山梨糖醇、木糖醇、甘露醇、麦芽糖醇、蜂蜜等）、调味品（如食盐、香精、味精、天然香料如花椒、茴香、孜然、桔皮、咖喱粉、辣椒、十三香等、食用油等）、增稠剂（如琼脂、桃胶、***胶、白芨胶、海藻酸钠等）。
本发明黑蒜山楂脆片的制作方法，是将净山楂饮片经干燥、粉碎成超微粉，将黑大蒜与水按重量比为1:1比例，置于球磨机中磨成糊状的黑大蒜糊，然后再将山楂粉与黑大蒜糊混合均匀，采用压片设备压制成型，烘干，包装即得。
其中所述的烘干为采用100℃～300℃的低温热风烘干6～9小时。对制成的黑蒜山楂脆片，为了便于储存和保质，可采用真空包装或充氮包装。
本发明以上所述的设备均为本领域常规设备。
山楂，别名红果子，为蔷薇科山楂属植物山里红Crataegus pinnatifida Bungevar.maior N.E.Br.、或山楂Crataegus pinnatifida Bunge的干燥成熟果实。
饮片性状：山楂呈类圆形片状，表面棕黄色，常卷曲皱缩，中间有成环状排列的浅黄色果核，多脱落。周边深红色，微有光泽，有细纵纹和灰白色小点，偶可见短细柄或凹窝。其化学成分，山楂果实含黄酮及其苷类化合物：主要苷元为芹菜素、木柰酚类、木犀草素、槲皮素及二氢黄酮类等。主要有牡荆素、异牡荆素、山楂苷A、B、C、D、I，红蓼素、异红蓼素等；黄烷醇类及其聚合物：儿茶素、表儿茶素、白矢车菊素、前化靛A2、前花青素B2、B4、B5、C1、D1、E1；有机酸类化合物：包括三萜类和其他有机酸，主要有熊果酸、齐墩果酸、山楂酸、科罗索酸、没食子酸、绿原酸、咖啡酸、酒石酸、枸橼酸等。从山楂根中分离得到芹菜素、2,3,4,6-四甲氧基-7-羟基二苯并呋喃。山楂具有消食化积，活血散瘀功效。临床常用于食滞不化、腹胀泄泻，产后瘀阻、恶露不尽等。现代药理研究具有：①促进胃酶分泌及脂肪类食物消化，增强酶活性，调整胃肠功能；②降血压，降血脂，增加冠状动脉血流，抗心律失常，增强心肌收缩力；③扩张血管，缓解血管痉挛，强心，抗心绞痛，抗心律失常；④抗菌；⑤驱绦虫；⑥缜痛；⑦抗血小板聚集；⑧保护视网膜；⑨抑制畸变（贾公孚，临床药物新用联用大全，2006年12月第2版，750页）。山楂与大蒜配合可以增强降压作用，并延长作用时间，此种降压效应是胆碱能神经样作用（贾公孚，临床药物新用联用大全，2006年12月第2版，741页）。
本发明的有益效果如下：
1、本发明一种黑蒜山楂脆片是由黑大蒜与山楂粉复配制作而成，将山楂粉碎成超细微粉能够使产品细腻，食后无渣，最大限度地保持了黑大蒜和山楂原有的营养成分及保健功效，而且根据不同的需要制得不同风味和风格的可口脆片，使人们在享受休闲食品的同时，也得到了黑大蒜和山楂的有益保健功效。
2、本发明是利用一种大蒜制品的加工方法（ZL201210249529.8）权利要求1步骤（二）的技术方案获得的黑大蒜成品，不仅使黑大蒜在食品加工中得到更多的有益应用，同时也完全保留了黑大蒜中的功效成分，也有效地克服了常规制备含大蒜食品中的辛辣和刺激性味道，而呈现黑大蒜的特殊功效。
3、由于本发明采用了制片工艺技术，避免了挥发性成分的散失，同时将包装采用真空包装或充氮包装，可有效防止产品中各有效成分的氧化或串味。
4、本发明加工工艺简单，易于掌控，生产成本低，无环境污染，能够实现工业化生产，适宜大众普及食用。作为一种新的黑蒜山楂脆片食品，具有很好的市场前景。
具体实施方式
下面结合实施例对本发明具体实施方式作进一步说明，不应看作是对本发明的限制，对以下优选的实施方式，对本领域的技术人员来说，在不脱离本发明方案技术原理的前提下进行的改进和润饰均应视为本发明的保护范围。
实施例1
（1）取净药材山楂饮片，采用电热烘箱于85℃～90℃烘干6～8小时，使水分含量小于2%，然后用超微粉碎设备粉碎成300目的超微粉，得山楂粉；（2）称取按ZL201210249529.8权利要求1步骤（二）技术方案制得的黑大蒜5公斤，加水5公斤，置于球磨机中，磨成糊状的黑大蒜糊，再与山楂粉95公斤充分混合均匀，同时加入L-***糖、琼脂，其中L-***糖和琼脂的用量按食品制作的常规用量计，混合均匀后，采用压片设备压制成型；（3）置于烘箱中，于100℃下烘干9小时；（4）烘干后的脆片，采用真空包装或充氮包装。
实施例2
（1）取净药材山楂饮片，采用电热烘箱于85℃～90℃烘干6～8小时，使水分含量小于2%，然后用超微粉碎设备粉碎成800目的超微粉，得山楂粉；（2）称取按ZL201210249529.8权利要求1步骤（二）技术方案制得的黑大蒜10公斤，加水10公斤，置于球磨机中，磨成糊状的黑大蒜糊，再与山楂粉90公斤充分混合均匀，同时还加入食用盐、味精、天然香料、食用油和海藻酸钠，其中食用盐、味精、天然香料、食用油和海藻酸钠的用量按食品制作的常规用量计，混合均匀后，采用压片设备压制成型；（3）置于烘箱中，于300℃下烘干6小时；（4）烘干后的脆片，采用真空包装或充氮包装。
实施例3
（1）取净药材山楂饮片，采用电热烘箱于85℃～90℃烘干6～8小时，使水分含量小于2%，然后用超微粉碎设备粉碎成600目的超微粉，得山楂粉；（2）称取按ZL201210249529.8权利要求1步骤（二）技术方案制得的黑大蒜8公斤，加水8公斤，置于球磨机中，磨成糊状的黑大蒜糊，再与山楂粉92公斤充分混合均匀，同时加入食用盐、味精、香精、食用油和琼脂，其中食用盐、味精、香精、食用油和琼脂的用量按食品制作的常规用量计，混合均匀后，采用压片设备压制成型；（3）置于烘箱中，于150℃下烘干7.5小时；（4）烘干后的脆片，采用真空包装或充氮包装。
实施例4
（1）取净药材山楂饮片，采用电热烘箱于85℃～90℃烘干6～8小时，使水分含量小于2%，然后用超微粉碎设备粉碎成500目的超微粉，得山楂粉；（2）称取按ZL201210249529.8权利要求1步骤（二）技术方案制得的黑大蒜7公斤，加水7公斤，置于球磨机中，磨成糊状的黑大蒜糊，再与山楂粉93公斤充分混合均匀，同时加入木糖醇、蜂蜜、***胶，其中木糖醇、蜂蜜和***胶的用量按食品制作的常规用量计，混合均匀后，采用压片设备压制成型；（3）置于烘箱中，于120℃下烘干8小时；（4）烘干后的脆片，采用真空包装或充氮包装。
实施例5
（1）取净药材山楂饮片，采用电热烘箱于85℃～90℃烘干6～8小时，使水分含量小于2%，然后用超微粉碎设备粉碎成700目的超微粉，得山楂粉；（2）称取按ZL201210249529.8权利要求1步骤（二）技术方案制得的黑大蒜15公斤，加水15公斤，置于球磨机中，磨成糊状的黑大蒜糊，再与山楂粉85公斤充分混合均匀，同时加入食用盐、味精、花椒、辣椒、食用油和海藻酸钠，其中食用盐、味精、花椒、辣椒、食用油和海藻酸钠的用量按食品制作的常规用量计，混合均匀后，采用压片设备压制成型；（3）置于烘箱中，于200℃下烘干7小时；（4）烘干后的脆片，采用真空包装或充氮包装。
实施例6
（1）取净药材山楂饮片，采用电热烘箱于85℃～90℃烘干6～8小时，使水分含量小于2%，然后用超微粉碎设备粉碎成400目的超微粉，得山楂粉；（2）称取按ZL201210249529.8权利要求1步骤（二）技术方案制得的黑大蒜4公斤，加水4公斤，置于球磨机中，磨成糊状的黑大蒜糊，再与山楂粉96公斤充分混合均匀，同时加入食用盐、味精、孜然、食用油和海藻酸钠，其中食用盐、味精、孜然、食用油和海藻酸钠的用量按食品制作的常规用量计，混合均匀后，采用压片设备压制成型；（3）置于烘箱中，于250℃下烘干6.5小时；（4）烘干后的脆片，采用真空包装或充氮包装。
Claims (6)
1.一种黑蒜山楂脆片，其特征是以山楂粉、黑大蒜为原料，经混合、成型、烘干而成；其中所述原料按以下重量百分比配比：山楂粉85%～99%，黑大蒜1%～15%。
2.如权利要求1所述的黑蒜山楂脆片，其特征在于，其中所述原料按以下重量百分比配比：山楂粉90%～95%，黑大蒜5%～10%。
3.如权利要求1所述的黑蒜山楂脆片，其特征在于，所述的山楂粉为300～800目的超微粉。
4.如权利要求1或2所述的黑蒜山楂脆片，其特征在于，其中所述原料中包括山楂粉、黑大蒜总重量1%～15%的添加剂。
5.如权利要求1所述的黑蒜山楂脆片的制作方法，其特征是将净山楂饮片经干燥、粉碎成超微粉，将黑大蒜与水按重量比为1:1比例，置于球磨机中磨成糊状的黑大蒜糊，然后再将山楂粉与黑大蒜糊混合均匀，采用压片设备压制成型，烘干，包装即得。
6.如权利要求5所述的黑蒜山楂脆片的制作方法，其特征在于，所述的烘干为采用100℃～300℃的低温热风烘干6～9小时。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611239169.8A CN106616622A (zh) | 2016-12-28 | 2016-12-28 | 一种黑蒜山楂脆片及其制作方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201611239169.8A CN106616622A (zh) | 2016-12-28 | 2016-12-28 | 一种黑蒜山楂脆片及其制作方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106616622A true CN106616622A (zh) | 2017-05-10 |
Family
ID=58837002
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201611239169.8A Withdrawn CN106616622A (zh) | 2016-12-28 | 2016-12-28 | 一种黑蒜山楂脆片及其制作方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106616622A (zh) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110973628A (zh) * | 2019-11-29 | 2020-04-10 | 江苏巨托生物科技有限公司 | 一种蒜氨酸食品添加剂及其制备方法 |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102240010A (zh) * | 2011-05-24 | 2011-11-16 | 山东巨野晨农永兴食品有限公司 | 一种黑蒜浓缩汁的生产方法及其应用 |
| CN103494135A (zh) * | 2013-09-09 | 2014-01-08 | 广西壮族自治区金秀瑶族自治县科学技术情报研究所 | 甜茶山楂片 |
| CN104026496A (zh) * | 2014-05-13 | 2014-09-10 | 蚌埠味多多学生营养餐有限公司 | 一种黑麦山楂片及其制备方法 |
| CN104026322A (zh) * | 2014-05-13 | 2014-09-10 | 蚌埠味多多学生营养餐有限公司 | 一种红薯山楂片及其制备方法 |
-
2016
- 2016-12-28 CN CN201611239169.8A patent/CN106616622A/zh not_active Withdrawn
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102240010A (zh) * | 2011-05-24 | 2011-11-16 | 山东巨野晨农永兴食品有限公司 | 一种黑蒜浓缩汁的生产方法及其应用 |
| CN103494135A (zh) * | 2013-09-09 | 2014-01-08 | 广西壮族自治区金秀瑶族自治县科学技术情报研究所 | 甜茶山楂片 |
| CN104026496A (zh) * | 2014-05-13 | 2014-09-10 | 蚌埠味多多学生营养餐有限公司 | 一种黑麦山楂片及其制备方法 |
| CN104026322A (zh) * | 2014-05-13 | 2014-09-10 | 蚌埠味多多学生营养餐有限公司 | 一种红薯山楂片及其制备方法 |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110973628A (zh) * | 2019-11-29 | 2020-04-10 | 江苏巨托生物科技有限公司 | 一种蒜氨酸食品添加剂及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104957298A (zh) | 养生茉莉花茶 | |
| CN103238798A (zh) | 一种石斛营养片及制备方法 | |
| CN103584022A (zh) | 一种补血养气的藕粉及其制备方法 | |
| KR101166883B1 (ko) | 당귀, 천궁, 갈근, 작약, 숙지황, 황기, 홍삼, 건강, 감초, 계피 및 대추로 이루어진 한방 혼합 침출차 조성물 및 그 제조방법 | |
| CN102669551A (zh) | 一种灵芝面条及其制作方法 | |
| CN105660958A (zh) | 荷叶莲子茶的制备方法 | |
| CN107692027A (zh) | 一种藤三七面条及其制备方法 | |
| CN102742705A (zh) | 黄精三叶茶 | |
| CN102618425B (zh) | 元宝枫保健酒及其制备方法 | |
| KR101338560B1 (ko) | 오디 및 한방조성물이 함유된 건강국수 제조방법 | |
| CN108236099A (zh) | 一种清火开胃西瓜子的制备方法 | |
| KR20130046547A (ko) | 간 기능개선용 쌀국수의 제조방법 | |
| CN105767993A (zh) | 一种润肺止咳桃果酱 | |
| CN106616622A (zh) | 一种黑蒜山楂脆片及其制作方法 | |
| CN103828895B (zh) | 一种茶油米皮及加工方法 | |
| KR20140038644A (ko) | 삼채 환의 제조방법 및 이로부터 제조된 삼채 환 | |
| CN102823870B (zh) | 一种玉竹粉丝的生产方法 | |
| CN105011182A (zh) | 一种养心宁神牛肉干的制备方法 | |
| CN106616621A (zh) | 一种燕麦麸黑蒜脆片及其加工方法 | |
| CN104082447A (zh) | 一种乌发美容保健茶及其制备方法 | |
| CN104323144A (zh) | 一种假蒌风味保健燕麦片 | |
| KR20200127114A (ko) | 밤을 포함하는 쌍화탕 및 그 제조방법 | |
| KR101661744B1 (ko) | 된장과 현미를 이용한 차 및 이의 제조방법 | |
| CN108607041A (zh) | 一种补气养阴的保健品的制备方法 | |
| CN106690165A (zh) | 大蒜脆片及其加工方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| TA01 | Transfer of patent application right | ||
| TA01 | Transfer of patent application right |
Effective date of registration: 20170922 Address after: Three No. 1, No. 221300, Pizhou hi tech Industrial Development Zone, Jiangsu, Xuzhou, China Applicant after: JIANGSU QIANYAOTANG STATE MEDICAL RESEARCH INSTITUTE CO., LTD. Applicant after: Xuzhou Lvzhiye Biological Food Co., Ltd. Address before: Three No. 1, No. 221300, Pizhou hi tech Industrial Development Zone, Jiangsu, Xuzhou, China Applicant before: JIANGSU QIANYAOTANG STATE MEDICAL RESEARCH INSTITUTE CO., LTD. |
|
| WW01 | Invention patent application withdrawn after publication | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20170510 |